Oxford Performance Materials, Inc.
www.oxfordpm.comOxford Performance Materials (OPM) is a recognized leader in materials technology and high performance additive manufacturing (HPAM™), delivering fully functional end-use products to the biomedical, aerospace and industrial markets. OPM was founded in 2000 with a simple purpose: to exploit the highly advanced molecule poly-ether-ketone-ketone (PEKK), and OPM remains the only company producing 3D printed PEKK-based products in today’s marketplace, including patient-specific medical implants and strong, lightweight parts for space, defense and commercial aircraft. OPM’s proprietary OXPEKK® composition, process and application technology provides high function at low cost, facilitating expansion into new industrial markets where applications demand a range of advanced performance characteristics, such as energy, semiconductor and automotive. OPM has obtained ISO 13485:2003 and ISO 9001:2008/AS9100C certification and has received FDA clearance for its OsteoFab® patient-specific cranial and facial devices as well as its SpineFab® vertebral body replacement (VBR) line.
Read moreOxford Performance Materials (OPM) is a recognized leader in materials technology and high performance additive manufacturing (HPAM™), delivering fully functional end-use products to the biomedical, aerospace and industrial markets. OPM was founded in 2000 with a simple purpose: to exploit the highly advanced molecule poly-ether-ketone-ketone (PEKK), and OPM remains the only company producing 3D printed PEKK-based products in today’s marketplace, including patient-specific medical implants and strong, lightweight parts for space, defense and commercial aircraft. OPM’s proprietary OXPEKK® composition, process and application technology provides high function at low cost, facilitating expansion into new industrial markets where applications demand a range of advanced performance characteristics, such as energy, semiconductor and automotive. OPM has obtained ISO 13485:2003 and ISO 9001:2008/AS9100C certification and has received FDA clearance for its OsteoFab® patient-specific cranial and facial devices as well as its SpineFab® vertebral body replacement (VBR) line.
Read moreCountry
State
Connecticut
City (Headquarters)
South Windsor
Industry
Founded
2000
Estimated Revenue
$1,000,000 to $5,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Director of Finance and Planning , and Board Member
Email ****** @****.comPhone (***) ****-****Marketing Director
Email ****** @****.comPhone (***) ****-****Director Customer Operations
Email ****** @****.comPhone (***) ****-****Senior Director of Operations and Quality Control
Email ****** @****.comPhone (***) ****-****
Technologies
(17)